Clinical Chemistry Siemens Point of Care - Urinalysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 45: 726-731, 1999;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leonard, D. G.B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leonard, D. G.B.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Laboratory Management
Right arrow Clinical Chemistry Forum
(Clinical Chemistry. 1999;45:726-731.)
© 1999 American Association for Clinical Chemistry, Inc.

Clinical Chemistry Forum

The Future of Molecular Genetic Testing

Debra G.B. Leonard

Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA 19104-4283. Fax 215-662-7529;

The potential applications for genetic testing are immense, with most diseases having some aspect influenced by, if not directly caused by, changes in the genome of the patient. The translation of genetic information into medical applications will be influenced by our understanding of the human genome, technological advances, and social, ethical, and legal issues surrounding genetic testing. With time, new genetic information will be translated into clinical tests for the diagnosis of current illness and prediction of future disease risk, and will be used for the development of genetically directed therapies and preventive interventions. Most genetic testing will be highly automated, with only rare genetic disease tests performed manually. The challenge for the clinical genetic laboratory is to keep pace with this information explosion to provide state-of-the-art genetic testing and to ensure that the genetic test results are used in a morally, ethically, and socially responsible way.© 1999 American Association for Clinical Chemistry




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
D. G.B. Leonard
Improved Method for Diagnosis of Charcot-Marie-Tooth Type 1A: Patent Pending?
Clin. Chem., May 1, 2001; 47(5): 807 - 808.
[Full Text] [PDF]

Home page
 Arch Pediatr Adolesc MedHome page
M. H. Farrell, L. K. Certain, and P. M. Farrell
Genetic Counseling and Risk Communication Services of Newborn Screening Programs
Arch Pediatr Adolesc Med, February 1, 2001; 155(2): 120 - 126.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. S. Young and D. G.B. Leonard
Issues in Genetic Testing
Clin. Chem., June 1, 1999; 45(6): 915 - 926.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
D. S. Young
Issues in Genetic Testing
Clin. Chem., May 1, 1999; 45(5): 725 - 725.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American Association for Clinical Chemistry.